Australia Pharmaceuticals & Healthcare Report Q1 2008 - Market Research Reports

Welcome - Home - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying

| More

Electronic

Australia Pharmaceuticals & Healthcare Report Q1 2008
Business Monitor International, Feb 2008, Pages: 79



		Description


	Table of Contents



		Companies Mentioned



		Enquire before Buying



		Send to a Friend

Executive Summary 5
Australia Pharmaceuticals And Healthcare Industry SWOT 6
Australia Political SWOT 7
Australia Economic Environment SWOT 7
Australia Business Environment SWOT 8
Business Environment Ratings 9
Pharmaceutical Ratings - Revised Methodology 9
Ratings Overview 9
Table: Pharmaceutical Business Environment Indicators 10
Weighting 11
Table: Weighting Of Components 11
Australia - Business Environment Ratings 12
Table: Asia Pacific Business Environment Rankings 12
Limits Of Potential Returns 12
Risks To Realisation Of Returns 13
Australia - Market Summary14
Regulatory Regime15
Regulatory Developments 16
Intellectual Property Issues 17
Trade Agreements 18
Pricing And Reimbursement 19
Table: Historical PBS Co-payments 20
Price Cuts 23
Industry Trends And Developments 25
Health Profile 25
Table: HIV/AIDS In Australia 25
Healthcare Expenditure 27
Domestic Pharmaceutical Sector 28
Domestic Sector Developments 28
Foreign Industry 30
Biotechnology And Research 31
Pharmacy Sector 33
Clinical Trials 34
Industry Forecast Scenario 36
Overall Market Forecast 36
Table: Australia’s Drug Market Expenditure Forecasts 37
Key Growth Factors - Industry 38
Table: Health Expenditure Forecasts, 2005-2012 39
Key Growth Factors - Macroeconomic 40
Table: Australia - Economic Activity 42
Prescription Market Forecast 43
Table: Australian Prescription Market Forecasts (US$mn unless otherwise stated) 44
OTC Market Forecast 45
Table: Australia OTC Market Forecast Indicators (US$mn unless otherwise stated) 46
Patented Drug Market And Forecasts 47
Table: Major Patent Expiries In Australia 48
Table: Generics And Branded Market Forecasts, 2005-2012 49
Export And Import Forecasts 50
Table: Sectoral Trade Indicators, 20005-2012 (US$mn) 51
Other Healthcare Data Forecasts 51
Table: Other Healthcare Data, 2005-2012 51
Key Risks To Ous Forecast Scenario 52
Competitive Landscape53
Table: Competitive Landscape In Australia - Leading Multinationals 53
Company Profiles54
Leading Multinationals 54
Pfizer 54
Sanofi-Aventis 56
GlaxoSmithKline 58
Merck & Co 61
Novartis 63
Roche 65
AstraZeneca 67
Eli Lilly 69
Indigenous Manufacturers 71
Sigma Pharmaceuticals 71
Australian Pharmaceutical Industries 73
Alphapharm 75
Herron Pharmaceuticals 76
Our Forecast Modelling77
How We Generate Our Industry Forecasts 77
Pharmaceutical Industry 78
Sources

Also available

Australia Pharmaceuticals and Healthcare Report Q2 2008

Australia Pharmaceuticals and Healthcare Report Q3 2008

Customers who bought this item also bought

Australia Pharmaceuticals and Healthcare Report Q3 2008

Australia Pharmaceuticals and Healthcare Report Q1 2010

Australia Pharmaceuticals and Healthcare Report Q4 2008

The Pharmaceutical Market: Australia

Australia Pharmaceuticals and Healthcare Report Q1 2009

Australia Pharmaceuticals and Healthcare Report Q2 2008

Australia Pharmaceuticals and Healthcare Report Q4 2009

Snapshots Australia Pharmaceuticals 2009

Australia – The National Broadband Network

Pharmaceuticals Wholesaling in Australia

Digestive Remedies in Australia

Medicated Skin Care in Australia

Top of page